𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning—a comparison of methods

✍ Scribed by H. B. W. Larsson; P. S. Tofts


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
172 KB
Volume
24
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Two recently published methods of blood‐brain barrier permeability measurement using Gd‐DTPA scanning are compared by authors representing each group. The physiological models are reconciled. Results from both groups agree. These show that the transfer constant (the permeability surface area product per unit volume of tissue) of the defective blood‐brain barrier in multiple sclerosis is in the range 1‐12·10^−4^s^−1^ © 1992 Academic Press, Inc.


📜 SIMILAR VOLUMES


Measurement of blood-brain barrier perme
✍ James Kenney; Udo Schmiedl; Kenneth Maravilla; Frank Starr; Michael Graham; Alex 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

## Abstract Sequential MR imaging with gadolinium‐diethylenetriaminepentaacetic acid (Gd‐DTPA) and sequential measurements of plasma Gd‐DTPA concentration by inductively coupled plasma atomic emission spectroscopy (ICP‐AES) were used to estimate the blood‐to‐tissue transport coefficient (K~i~) in t

Measurement of the blood-brain barrier p
✍ Paul S. Tofts; Allan G. Kermode 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Leakage of Gd-DTPA through a defective blood-brain barrier is measured quantitatively using dynamic MRI scanning, in which repeated scans are made after a bolus injection. Image registration artifacts are minimized; a dose of 0.1 mM/kg and an IR sequence enable enhancement to be measured quantitativ

Quantitative measurement of blood-brain
✍ Saeid Taheri; Charles Gasparovic; Nadim Jon Shah; Gary A. Rosenberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

## Abstract Breakdown of the blood‐brain barrier (BBB), occurring in many neurological diseases, has been difficult to measure noninvasively in humans. Dynamic contrast‐enhanced magnetic resonance imaging measures BBB permeability. However, important technical challenges remain and normative data f